Related Experiment Video
Updated: Jul 27, 2026

Lentivirus Production
Published on: October 2, 2009
Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory
E J Sampson1, J R Barr, S K Cordovado
1National Center for Environmental Health, National Diabetes Laboratory, Centers for Disease Control and Prevention, Division of Laboratory Sciences, Atlanta, Georgia, USA. ejs1@cdc.gov
Abstract:
In 1997, the Centers for Disease Control and Prevention established the National Diabetes Laboratory in order to help prevent and treat type 1 diabetes. This state-of-the-art laboratory collaborates with research scientists and key national and international organizations throughout the world to identify and study risk factors for type 1 diabetes by developing measurements for glycosylated proteins, developing and evaluating technology for measuring genetic risk factors for the disease, and working to standardize autoantibody measurements. Developing improved technologies for diagnosing and managing diabetes and developing reference materials for properly calibrating and standardizing blood glucose meters are also critical aspects of the laboratory's work. In addition, the laboratory provides quality storage for valuable collections of biologics and other materials and facilitates sharing of specimens, associated epidemiologic data, and test results. Working with our partners in diabetes research, we are improving the diagnosis, treatment, and prevention of type 1 diabetes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
Investigation of Disease Outbreaks
Diabetes Mellitus: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

